BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma

BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma

<p><strong>Background and Aims</strong></p> The dismal prognosis of pancreatic ductal adenocarcinoma (PDAC) is linked to the presence of pancreatic cancer stem-like cells (CSCs) that respond poorly to current chemotherapy regimens. The epigenetic mechanisms regulating CSCs ar...

Descripció completa

Dades bibliogràfiques
Autors principals:	Feng, Y, Cai, L, Pook, M, Liu, F, Chang, C-H, Mouti, MA, Nibhani, R, Militi, S, Dunford, J, Philpott, M, Fan, Y, Fan, G-C, Liu, Q, Qi, J, Wang, C, Hong, W, Morgan, H, Wang, M, Sadayappan, S, Jegga, AG, Oppermann, U, Wang, Y, Huang, W, Jiang, L, Pauklin, S
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2023

Ítems similars

SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell cycle inhibitors to guide tissue formation
per: Militi, S, et al.
Publicat: (2024)

Mechanisms of cancer cell death: Therapeutic implications for pancreatic ductal adenocarcinoma
per: Pook, H, et al.
Publicat: (2021)

TGFB1/INHBA homodimer/nodal-SMAD2/3 signaling network: a pivotal molecular target in PDAC treatment
per: Abdel Mouti, M, et al.
Publicat: (2021)

Rewiring of 3D chromatin topology orchestrates transcriptional reprogramming and the development of human dilated cardiomyopathy
per: Feng, Y, et al.
Publicat: (2022)

RBL2-E2F-GCN5 guide cell fate decisions during tissue specification by regulating cell-cycle-dependent fluctuations of non-cell-autonomous signaling
per: Militi, S, et al.
Publicat: (2023)

KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics
per: Mouti, MA, et al.
Publicat: (2023)

Molecular therapeutics of pancreatic ductal adenocarcinoma:targeted pathways and the role of cancer stem cells
per: Stoica, A, et al.
Publicat: (2020)

Mitochondrial nucleoid in cardiac homeostasis: bidirectional signaling of mitochondria and nucleus in cardiac diseases
per: Feng, Y, et al.
Publicat: (2021)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
per: Cribbs, AP, et al.
Publicat: (2021)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
per: Wang, L, et al.
Publicat: (2015)

Development of chemical probes for the bromodomains of BRD7 and BRD9
per: Clark, P, et al.
Publicat: (2016)

The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms
per: Chang, C-H, et al.
Publicat: (2024)

BRD3 and BRD4 BET bromodomain proteins differentially regulate skeletal myogenesis
per: Roberts, T, et al.
Publicat: (2017)

PAF1 regulates the stemness of pancreatic cancer stem cells
per: Feng, Y, et al.
Publicat: (2021)

The T cell architecture of pancreatic ductal adenocarcinoma
per: Sivakumar, S, et al.
Publicat: (2019)

The T-cell architecture of pancreatic ductal adenocarcinoma
per: Sivakumar, S, et al.
Publicat: (2019)

Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome.
per: Bevan, S, et al.
Publicat: (1999)

Light flight : an orchestrated perception
per: Wang, Yang,S.M.Massachusetts Institute of Technology.
Publicat: (2020)

Imaging p53 in pancreatic ductal adenocarcinoma
per: Koustoulidou, S
Publicat: (2017)

PKM2 is not required for pancreatic ductal adenocarcinoma
per: Danai, Laura V, et al.
Publicat: (2018)

Chemically modified neoantigen-based immunotherapy for targeting KRASG12C-driven tumors
per: Abdel Mouti, M, et al.
Publicat: (2023)

A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response.
per: Chau, J, et al.
Publicat: (2012)

Epigenetic and transcriptional regulations prime cell fate before division during human pluripotent stem cell differentiation
per: Madrigal, P, et al.
Publicat: (2023)

Immuno-phenotypes of Pancreatic Ductal Adenocarcinoma: Metaanalysis of transcriptional subtypes
per: De Santiago, I, et al.
Publicat: (2018)

The evolutionary landscape of colorectal tumorigenesis
per: Cross, W, et al.
Publicat: (2018)

Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
per: De Santiago, I, et al.
Publicat: (2019)

Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo.
per: Arnold, S, et al.
Publicat: (2006)

Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo
per: Arnold, S, et al.
Publicat: (2006)

Smad signal transduction : Smads in proliferation, differentiation and disease /
per: Dijke, Peter Ten, et al.
Publicat: (2006)

Smad2 positively regulates the generation of Th17 cells.
per: Martinez, G, et al.
Publicat: (2010)

Identifying genes that are required for the maintenance of pancreatic ductal adenocarcinoma
per: Jenq, Harry
Publicat: (2013)

Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
per: Koustoulidou, S, et al.
Publicat: (2016)

Towards verification of computation orchestration
per: Dong, Jin Song, et al.
Publicat: (2013)

A review of lifestyle, metabolic risk factors and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma
per: Pang, Y, et al.
Publicat: (2018)

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
per: Lau, Allison N, et al.
Publicat: (2021)

An epigenetic screen identifies bromodomain-containing protein 4 (BRD4) as a critical component for osteoblast differentiation
per: Kramm, A, et al.
Publicat: (2013)

PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
per: Dushek, O, et al.
Publicat: (2016)

Denervation suppresses gastric tumorigenesis
per: Zhao, Chun-Mei, et al.
Publicat: (2015)

Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice.
per: Pangas, SA, et al.
Publicat: (2008)

A nitroreductase-activatable metabolic reporter for covalent labeling of pathological hypoxic cells in tumorigenesis
per: Wang, Zhimin, et al.
Publicat: (2025)